At its core, Soligenix is a late-stage biopharmaceutical company that thrives at the intersection of urgent medical need and scientific…
Two former officials at the NIH have filed whistleblower complaints in which they allege that their removal from office was…
Nutriband sustains itself through multiple revenue-generating subsidiaries At the core of the company’s innovation is the AVERSA(TM) platform, a proprietary…
IzoView Breast CT designed as the first breast-dedicated CT imaging system to eliminate tissue overlap and compression limitations specifically for…
The NCI, or National Cancer Institute, a federal body, has revealed that it will no longer fund a program that…
The FDA’s orphan drug designation for dusquetide follows encouraging phase 2a clinical trial results demonstrating both biological efficacy and a…
According to new research published in the journal Cell, targeting the SOX6 protein could open a new way to repair…
The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic cancer and is advancing toward combination…
BreastCT.com launches as a comprehensive educational resource focused on dedicated breast CT technology and IzoView's clinical advantages for dense breast…
The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually.…